These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10649688)

  • 1. Saccharides as osmotic agents in peritoneal dialysate: determination of molecular weight essential for more efficient fluid removal.
    Yokota S; Kumano K; Ma P; Hyodo T; Sakai T; Izumi G; Hashimoto A; Shibata K; Wang H
    Adv Perit Dial; 1998; 14():40-3. PubMed ID: 10649688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrafiltration failure and dialysate glucose in CAPD.
    Stegmayr B; Granbom L; Karlsson UM; Lindqvist B
    Adv Perit Dial; 1993; 9():62-4. PubMed ID: 8105964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
    García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of anaesthesia on fluid and solute transport in a C57BL6 mouse model of peritoneal dialysis.
    Shin SK; Kamerath CD; Gilson JF; Leypoldt JK
    Nephrol Dial Transplant; 2006 Oct; 21(10):2874-80. PubMed ID: 16877489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A detailed analysis of sodium removal by peritoneal dialysis: comparison with predictions from the three-pore model of membrane function.
    Aanen MC; Venturoli D; Davies SJ
    Nephrol Dial Transplant; 2005 Jun; 20(6):1192-200. PubMed ID: 15827048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of several saccharides as osmotic agent for peritoneal dialysate.
    Tomo T; Shibata T; Nasu M; Shibata K; Izumi G; Sofue K
    Perit Dial Int; 2000; 20(6):727-33. PubMed ID: 11216567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrafiltration capacity and peritoneal fluid kinetics in continuous ambulatory peritoneal dialysis patients.
    Zhe XW; Tian XK; Cheng L; Wang T
    Artif Organs; 2008 Jan; 32(1):61-5. PubMed ID: 18181804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal pressure, peritoneal permeability and volume of ultrafiltration in CAPD.
    Durand PY; Chanliau J; Gamberoni J; Hestin D; Kessler M
    Adv Perit Dial; 1992; 8():22-5. PubMed ID: 1361791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B; Levin L
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal addition of hyaluronan improves peritoneal dialysis efficiency.
    Wang T; Cheng HH; Heimbürger O; Chen C; Waniewski J; Bergström J; Lindholm B
    Perit Dial Int; 1999; 19 Suppl 2():S106-11. PubMed ID: 10406503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal hydrostatic pressure and ultrafiltration volume in CAPD.
    Durand PY; Chanliau J; Gambéroni J; Hestin D; Kessler M
    Adv Perit Dial; 1993; 9():46-8. PubMed ID: 8105960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
    Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
    J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three chronic dialysis models.
    Peng WX; Guo QY; Liu SM; Liu CZ; Lindholm B; Wang T
    Adv Perit Dial; 2000; 16():51-4. PubMed ID: 11045261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of surface tension of dialysate depending on its composition in continuous ambulatory peritoneal dialysis.
    Jeleniewicz R; Majdan M; Buraczyńska K; Portala P; Majdan M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):290-5. PubMed ID: 12898852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short peritoneal equilibration test: impact of preceding dwell time.
    Twardowski ZJ; Prowant BF; Moore HL; Lou LC; White E; Farris K
    Adv Perit Dial; 2003; 19():53-8. PubMed ID: 14763034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating peritoneal fluid transport in continuous peritoneal dialysis patients: a practical approach.
    Zhe XW; Tian XK; Shan YS; Cheng L; Wang T
    Nephron Clin Pract; 2007; 107(4):c123-7. PubMed ID: 17957122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid increases peritoneal ultrafiltration volume in patients on CAPD.
    Kuriyama S; Nakayama M; Tomonari H; Kawaguchi Y; Hosoya T
    Perit Dial Int; 1999; 19(1):38-44. PubMed ID: 10201339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
    Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
    Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis.
    Akman S; van Westrhenen R; De Waart DR; Hiralall JK; Zweers MM; Krediet RT
    Adv Perit Dial; 2003; 19():24-7. PubMed ID: 14763029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.